poisar

Stocks · News reference

Earnings Scheduled For September 17, 2026

Benzinga Insights

Companies Reporting Before The Bell • 111 (NASDAQ:YI) is projected to report earnings for its second quarter. • Innate Pharma (NASDAQ:IPHA) is projected to report quarterly loss at $0.16 per share on revenue of $9.10

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

IPHAUPXIYI
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  2. Benzinga Insights

    Innate Pharma H1 2026 Earnings Call Transcript

    Innate Pharma (NASDAQ:IPHA) held its quarterly earnings conference call on Thursday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data and

    IPHA
  4. SEC EDGAR

    8-K filing — UPEXI, INC. (UPXI)

    Filed: 2026-10-13 AccNo: 0001477932-26-006194 Size: 4 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

    UPXI
  5. Na

    Upexi to Participate in Upcoming October Investor Conferences

    Upexi, Inc. (NASDAQ: UPXI), a Solana-focused digital asset treasury company, announced that Chief Strategy Officer Brian Rudick will participate in three major investor conferences in October 2026: Maxim Growth Summit, Webull Emerging & Innovative Companies Webinar, and LD Micro 20th Annual Main Event. The company currently holds over 2.34 million SOL and reported digital asset revenue of $17.4 million for fiscal year 2026.

    UPXI